In a report released today, Sandy Draper from SunTrust Robinson reiterated a Buy rating on Charles River Labs (CRL), with a price target of $150. The company’s shares closed yesterday at $136.23, close to its 52-week high of $138.89.
Draper has an average return of 26.0% when recommending Charles River Labs.
According to TipRanks.com, Draper is ranked #158 out of 4918 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Charles River Labs with a $139.63 average price target, which is a 2.5% upside from current levels. In a report released yesterday, Robert W. Baird also maintained a Buy rating on the stock with a $148 price target.
.
See today’s analyst top recommended stocks >>
Charles River Labs’ market cap is currently $6.54B and has a P/E ratio of 51.80. The company has a Price to Book ratio of 5.53.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions.
